Atsunari Kawashima

55PUBLICATIONS
63CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNon-Newtonian fluid flows (incl. rheology)NanomedicineCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (55)

|Sep 11, 2026
Belzutifan-Associated Reversible Heart Failure With Preserved Ejection Fraction in Metastatic Renal Cell Carcinoma.

|Aug 24, 2026
Prognostic significance of the FAN score in patients with advanced urothelial carcinoma treated with enfortumab vedotin monotherapy.

|Jul 31, 2026
[18F]PSMA-1007 PET-Based Recurrence Site Distribution and Predictors of Metastatic Disease in Patients With Biochemical Recurrence of Prostate Cancer.

|Jul 29, 2026
Successful Closure of Persistent Urinary Fistula After High-Grade Renal Trauma Using N-Butyl-2-Cyanoacrylate: A Case Report.

|Jul 20, 2026
Short-term efficacy and safety of enfortumab vedotin plus pembrolizumab as a first-line treatment for advanced urothelial carcinoma regardless of cisplatin eligibility.

|Jul 15, 2026
Successful Treatment of Primary Mediastinal Seminoma With Radiotherapy Following Chemotherapy Under a Bloodless Treatment Policy Based on Patient's Religious Sentiments.

Pageof 10

Frequent Collaborators

28 joint publications

Taigo Kato

15 joint publications

Yoshiyuki Yamamoto

15 joint publications

Koji Hatano

9 joint publications

Yoichi Kakuta